Company sacks a further 155 employees in “re-engineering” efforts.
Biotech specialises in autoimmune disorder drugs.
Frazier takes swipe at price-hiking generics firms.
Merrimack sells off Onivyde and generic cancer drug
IBM Watson for Genomics will inform cancer treatment decisions by analysing Illumina’s genetic data.
Pharma M&A could surge in 2017, says report
Companies to develop bispecific antibodies.
But analysts excited by promise of next generation of medicines.
Money will go towards commercial launch of its R&D services.